Bovine Serum Albumin Market is Growing due to Changing Consumer Preferences for a Protein-Rich Diet

The global bovine serum albumin market is projected to grow from USD 254.8 million in 2019 to USD 304.2 million by 2025, at a CAGR of 3.0%. The global bovine serum albumin market is growing due to changing consumer preferences for a protein-rich diet and high demand from the life sciences industry.

Download PDF Brochure

Most research organizations make use of bovine serum albumin as a protein standard. It is used to determine the unknown quantities of other proteins by comparing the known quantities of bovine serum albumin. For instance, it is used in Bradford protein assay, a method used to measure the concentration of total protein in a sample, as the stable nature of the serum albumin helps in increasing the signal in assays.

Also, bovine serum albumin does not have any effect on many biochemical reactions, which makes scientists in the industry prefer it.. It is relatively cheaper than other protein standards due to large quantities of it, which can be easily purified from bovine blood. Some of its other characteristics, which make it a preferred product, include its highly pure nature and its high solubility in water due to which it is finding increased application in the pharmaceutical and diagnostics industries.

It has been established that this serum albumin is a dietary whey protein that has anti-obesity effects. A research experiment funded by the Republic of Ireland, which is responsible for research and development, training, and advisory services in the food & beverage industry, stated that the intake of BSA as a part of the low-fat diets prevents weight gain. Since obesity is a global problem that has high costs associated with it, the need for a cost-effective solution to tackle the issue of obesity is growing. BSA is a protein that can be easily sourced as a by-product of cheese manufacturing due to which the cost of using it as a potent dietary solution is higher.

Make an Inquiry

Key players are Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc (US), Merck KGAA (Germany), Itoham Yonekyu Holdings Inc (Japan), Proliant Biologicals (US), Kraeber & Co Gmbh (Germany), Rockland Immunochemicals Inc (US), Rocky mountain biologicals (US), BelHealth investment partners, LLC (US), Bio-Techne Corporation (US), Prospec-Tany Technogene Ltd (Israel), LGC Group (UK), Promega Corporation (US), Biological Industries (Israel), and Serion GmbH (Germany).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441